Status:
UNKNOWN
OCT Angiography in Vitreo and Chorioretinal Pathologies
Lead Sponsor:
CRG UZ Brussel
Conditions:
Optical Coherence Tomography
Eligibility:
All Genders
18-85 years
Brief Summary
In many diseases of the vitreo and chorioretinal complex, perfusion changes have a diagnostic, prognostic or causative role. The visualisation of perfusion was limited to invasive techniques, which we...
Eligibility Criteria
Inclusion
- Patient with vitreo and chorioretinal pathology, aged-adapted controls
Exclusion
- Minors, concomitant ocular pathologies, pregnancy, contra-indication for tropicamide
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03390205
Start Date
February 1 2018
End Date
March 1 2019
Last Update
January 4 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.